CanniMed Therapeutics Inc (TSE:CMED) insider Allan Mclay Fowler sold 31,777 shares of the stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of C$31.81, for a total transaction of C$1,010,826.37.
CanniMed Therapeutics Inc (TSE:CMED) traded up C$0.28 during trading on Monday, reaching C$35.58. 306,360 shares of the company were exchanged, compared to its average volume of 787,016. CanniMed Therapeutics Inc has a 12 month low of C$7.32 and a 12 month high of C$46.00. The stock has a market cap of $869.34 and a price-to-earnings ratio of -31.77.
TRADEMARK VIOLATION WARNING: “Allan Mclay Fowler Sells 31,777 Shares of CanniMed Therapeutics Inc (CMED) Stock” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/12/allan-mclay-fowler-sells-31777-shares-of-cannimed-therapeutics-inc-cmed-stock.html.
About CanniMed Therapeutics
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.